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The immense problem of chronic airway ob-
struction (CAO)-emphysema and chronic bron-
chitis-which has now reached epidemic propor-
tions, presents to the practitioner of medicine an 
increasing number of suffering persons asking for 
care. These patients are dyspneic, anxious, be-
wildered by their predicament, sometimes de-
manding and frightened about prospects for fu-
ture comfortable life. 
Although there has been a tremendous up-
surge of interest in the field of respiratory care, 
and a growing number of nebulizers, humidifiers, 
physical therapy techniques and drugs, all of the 
answers on emphysema care are not in. We must 
admit as physicians that although we are absolutely 
sure that we save many lives in the organized in-
tensive respiratory care unit in the case of acute 
respiratory failure (3, 13), no study has thus far con-
vinced the critics of respiratory care that the nat-
ural course of CAO is altered from the standpoint 
of survival. Nonetheless, today's patients cannot 
wait for all the answers. They flock to hospitals, 
clinics, and physicians' offices, seeking some re-
lief of their symptoms, some hope for improve-
ment in their status and for prolonged survival. 
It is therefore mandatory for all physicians inter-
ested in chest medicine and interested in their 
sick patients, to provide some form of service for 
* Presented by Dr. Petty at the Symposium on Respi-
ratory Failure, May 26, 1972, at Richmond, Virginia. Re-
printed with permission from Chest, Volume 58, pp. 
441-448, October, 1970. Supported in part by USPHS Con-
tract # 108-66-227, Chronic Respiratory Diseases Control 
Program. Reprint requests to Thomas L. Petty, M.D., 4200 
East Ninth Avenue, Denver, Colorado 80220. 
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the growing crowd of puffers and coughers-both 
pink and blue. 
This communication defines a practical clinic 
and outpatient treatment regimen that is applic-
able for most individuals suffering severe CAO with 
disability. 
Ambulatory Care Program. 
Patient Education. The management of any 
chronic disease must be based upon a high level 
of patient indoctrination and education. This has 
been the reason for success in large measures in di-
abetes mellitus management where for years, the 
sufferer has been instructed in nutrition, activity, 
insulin dosage, self-management, evaluation of gly-
cosuria and proper clothing, leading to the develop-
ment of an adjustment to the burdens of disease 
designed for a maximum of serenity in daily life. 
It does not take a great deal of talent, although it 
does take time, to desctibe the airways, the lungs, 
the circulation and to explain what is wrong in 
the emphysema-chronic bronchitis spectrum. The 
office nurse or clinic nurse, once properly trained 
herself, is a superb individual to assume the re-
sponsibility for this task. Patients receive an in-
depth discussion of general care with reinforcement 
in specific instructions guided by the physician's 
explicit prescription. These sessions are supple-
mented by a simple treatment manual ( 17) de-
signed to give the patient material for serious read-
ing which will reinforce the personal instruction 
and probably develop new questions for the nurses 
on revisits. We not only teach the patients about 
their disease process, but what physicians, nurses, 
and therapists are trying to do in their therapeutic 
endeavors. We stress the specific facets in man-
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agement listed below with details stressed for 
each individual patient. 
Bronchial Hygiene. Much of therapy must 
be directed at the bronchial element of disease. In 
many cases we are dealing with the bronchospasm, 
mucosa! edema, retained secretions, and impaired 
mucociliary clearance. Each patient must learn an 
effective method of bronchial hygiene to be used 
each day. Fundamental, of course, is the absolute 
cessation of smoking. This is best handled in a 
nursing session where the threat of a physician 
and his authority is less traumatic to the patient. 
In specific therapy, individuals are taught to 
inhale a bronchodilator aerosol followed by mois-
ture, followed by expulsive coughing on a system-
atic basis at least twice daily. One of the sympa-
thomimetic amines is inhaled for a period of at 
least ten deep breaths and a duration of, at times, 
up to ten minutes. Isoetharine with phenylephrine 
or racemic epinephrine or isoproterenol is used 
for this purpose. Aerosolized bronchodilators are 
delivered by a variety of devices, including a sim-
ple hand bulb nebulizer which does require some 
patient coordi.nation and strength, the newly avail-
able pump driven nebulizers1 ot simple hand 
held IPPB devices which have recently been pro-
vided for the practitioner2 ( fig . 1 ) . Ordinarily the 
drug is diluted with equal amounts of water with 
individual adjustments based upon side effects and 
apparent clinical efficacy. Bronchodilators relieve 
muscular spasm, combat mucosa! edema, and prob-
ably stimulate mucociliary cleararice ( 8, 10). The 
use of bronchodilator drugs must become an art 
with final judgment on the absolute details of ther-
apy, a joint effort between patient and physician, 
a matter which obviously requires a great trust and 
orientation on the part of both. 
Following the bronchodilator administration, 
inhaled moisture is the next step. This may be 
done by simple steaming devices, that is, a nursery 
humidifier, tea kettle, facial sauna and in some 
cases a more advanced nebulizer including an ul-
trasonic nebulizer. The choice of device is a mat-
ter of judgment based upon the ability to thin and 
raise secretions. It should be said artd emphasized 
that general hydration in the form of adequate 
water intake is fundamental in maintaining ade-
1 Maxi-Myst pump driven nebulizer, Mead Johnson Co., 
Evansville, Indiana. 
2 Hand-E-Vent, Ohio Medical Products, Madison, Wis-
consin. 
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Fig. 1-Hand held IPPB device suitable for hospital or 
home use. It is used in the home with compressor pump and 
has pressure flow characteristics similar to conventional 
ventilators. 
quate mucociliary clearance. The purpose of the 
moisture, of course, is to help thin secretions, 
which also facilitates mucociliary clearance. After 
approximately ten minutes of moisture inhalation, 
expulsive forceful coughing helps clear retained 
secretions. If these endeavors are insufficient, sim-
ple postural drainage techniques over pillows in 
bed often help the situation ( 18, 19). At times 
pummeling, or so-called clapping, is useful in re-
moving secretions (fig. 2). This is usually taught 
the spouse by the physical therapist. 
Fig. 2-Technique of percussion taught by physiotherapist. 
This often aids mucociliary clearance. 
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Breathing retrammg stressing abdominal-di-
aphragmatic control, allowing the abdomen to pro-
trude during inspiration, followed by forceful 
abdominal contractions during expiration, probably 
helps empty the lung and improves the efficiency 
of breathing ( 1, 2, 11) . These maneuvers with 
exhalation against pursed lips, have been learned 
by many individuals who suffer dyspnea and who 
learn that this is a means of relief of symptoms. 
In a clinical study the pursed-lip maneuver has 
been shown to reduce the oxygen ventilation 
equivalent, reduce alveolar-arterial oxygen differ-
ence and the necessary minute ventilation for 
a given level of arterial oxygen tension (12). 
Therefore the pursed-lip breathing maneuver en-
hances oxygen transport or at least is a more ef-
ficient breathing technique. This should be taught 
to all patients or at least tried in patients who are 
well indoctrinated in modern methods of emphy-
sema care. 
Physical reconditioning in the form of simple 
daily exercises with increasing goals from the stand-
point of more activity, has been shown to greatly 
improve exercise ability ( 6, 22) . Most patients can 
be taught to participate in comfortable exercise on 
an increasing basis in spite of the fact that their 
level of chronic airway obstruction may not change 
a great deal in response to therapy (20) . None-
theless, this training is an important activity for it 
provides increased facility for daily living. Most 
patients with chronic airway obstruction find dys-
pnea on exertion their most disabling symptom 
and any improvement in comfortable mobility can 
be translated into a better life. Figure 3 demon-
strates the measured improved walk tolerance at 
various rates and grades for an individual trained 
daily for the first week and every other day for the 
second week as part of a rehabilitation program. 
No measurable change in ventilatory function or 
blood gases (arterial) were observed during this 
brief training perioda. 
Oxygen. The clinical benefit of ambulatory ox-
ygen therapy has been repeatedly demonstrated 
(9, 15). In brief, oxygen is valuable for the hypox-
emic bronchitic person who is markedly disabled 
and suffers from heart failure. Oxygen has beeh 
shown to reduce the level of pulmonary hyper-
tension by reducing pulmonary arteriolar resis-
tance and also helps combat the seco:idary poly-
a MVV 31 L: FEY, 0.91 L. 
PETTY: EMPHYSEMA AND CHRONIC BRONCHITIS 
v, 
!!!, 
;!. 
v, 
.... 
... 
... 
~ 
I 
... 
u 
z 
! 
v, 
0 
~ 
0 
< 
... 
"' .... 
WALK TOLERANCE DURING GRADED EXERCISE 
120 
100 
80 
60 
3000 
2500 
2000 
1500 
1000 
500 
'1 • mph 
3:1mph 
1 
~- ~~~~ - 0" 01pod• / 
30~ 
/ 
1 'lmph 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
DA YS 
Fig. 3-lmproved walk tolerance at increasing rate and 
grade following daily training for two weeks. 
cythemia of the bronchitic hypoxemic state (9) . 
The development of a home based portable oxy-
gen system has inade the use of continuous ambula-
tory oxygen a reality. Figures 4 and 5 demonstrate 
the apparatus in common use today. The lower 
canister contains a liquid oxygen supply which 
usually suffices for three to four days. This can-
ister is capable of filling a smaller device which 
now provides three to six hours of oxygen ther-
apy. The duration is a function of rate of oxygen 
administration controlled by a flow rate mechanism 
on the device. Ambulatory oxygen provides for 
additional mobility. Experience with these de-
vices for over four years has proved the efficacy 
and safety in over 200 patients with profound hy-
poxemia who cannot gain mobility by any other 
means. 1 
Pharmacologic Therapy. The weight of cur-
rent evidence suggests that the immedlate lise of 
antibiotics for specific episodes of bronchitis man-
ifested by increasing cough, leukocytosis, elevated 
temperature, and purulent appearing sputum is 
effective in reducing the duration of symptoms and 
fever. Since the most common invading bacterial 
organisms after the original insult, which may be 
viral, appear to be D. pneumonia and H. infiuenza, 
the rather empiric use of ampicillin or tetracycline 
seems advisable. Ampicillin is usually given in 
doses of 4 g daily the first two days followed by 
2 g daily for three or four days. Tetracycline is 
usually given in 2 g doses daily the first two days 
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Fig. 4-Linde oxygen walker system. Lower container has 
approximately 3V2 days oxygen supply. This can be used 
directly or used to fill the 7.5 pound canister which the 
patient uses for ambulatory oxygen therapy. 
followed by 1 g daily for the duration of therapy, 
which usually covers five to seven days. Many 
patients with CAO are provided with a supply of 
antibiotics for home use to be instituted at first 
signs of a deep chest infection. It is also wise, how-
ever, from the standpoint of communication and 
further advice, to have these individuals contact 
their physician at the time of institution of these 
drugs. 
Digitalis and diuretic drugs are useful in the 
management of cor pulmonale with heart fail-
ure. These drugs, however, are fraught with the 
difficulty of arrhythmia, but the weight of evi-
dence in recent years indicates that an improved 
hemodynamic state can be achieved with digital-
izing doses of cardiac glycosides along with the 
use of diuretics if adequate correction of hypox-
emia is employed to provide adequate oxygenation 
of the myocardium and to control the reactive pul-
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Fig. 5-Patient carrying Linde oxygen walker system. De-
pending upon flow, three to five hours supply is available. 
monary hypertension associated with the hypox-
emic state ( 15). 
The corticosteroid drugs are definitely use-
ful in some patients with chronic airway obstruc-
tion. Indications for their use include the bron-
chitic patient with marked cough, expectoration, 
and repeated bouts of wheezing or choking spells 
superimposed upon the chronic symptom com-
plex. Often these individuals have significant 
changes in their expiratory flow parameters as 
they are observed serially. Generally, prednisone 
30 mg daily for the first five days, followed by a 
dose of 15 mg daily for the next five days, fol-
lowed by a low maintenance dose ·of 5 to 10 mg, 
with decisions for further therapy guided by mea-
surements of expiratory flow in the form of forced 
expiratory volume in one second (FEV1 ) or max-
imum mid-expiratory flow (MMEF). A certain 
number of patients with apparent chronic irre-
versible airway obstruction actually have a revers-
ible component of disease if observed carefully 
under steroid therapy ( 14) . 
Oral bronchodilators may be useful in an oc-
casional patient. The only harm of the ephedrine-
containing drugs aminophylline, amytal, and eph-
edrine HC l ( Amesec®), theophylline, pheno-
barbital, ephedrine HCl (Tedra]®), and so forth, 
is occasional urinary tract obstruction. Although 
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these drugs are not very effective, they are fre-
quently used by patients for reasons good or bad. 
Soluble xanthines in the form of oxtriphylline 
(Brondecon®) or choline theophyllinate (Chole-
dyl®) may also prove useful in some patients. 
The expectorants such as saturated solution 
potassium iodide and guaiacolate have not been 
proved by critical study to be effective in patients 
within this spectrum. Nonetheless, they may be 
used for apparent symptomatic benefit for short 
periods but should not be an agent of prolonged 
use. Polyvalent influenza vaccine should be given 
each fall for whatever protection is afforded. 
Occupational Therap y, Hobbies, and Change 
of Life Style. If life is to be worthwhile for the 
emphysema-bronchitis patient, it has to have mean-
ing. The details of therapy enumerated above 
should not be excessively demanding from the 
standpoint of time and should be applied in a sys-
tematic manner to allow patients to lead a happy 
and hopefully productive life. A number of pa-
tients can be returned to work. Return to work, 
of course, has to do with many factors and is basi-
cally based upon the energy requirement of the 
job, the patient's physiologic resources, and the 
patient's personal motivation to maintain a gain-
ful status ( 16) . Certainly the provision of ambula-
tory oxygen therapy is a great aid for some pa-
tients (15, 16). Additional oxygen provides for 
additional activity and improvement in work ca-
pacity while on the job. 
For those not so fortunate, occupational ther-
apy in the form of hobbies is tremendously im-
portant. Many patients have a longing or desire 
to paint, write, garden, golf, or simply walk around 
a bit. This should be encouraged by the total ap-
plication of the program described above. 
Effectiveness of Today's Ambulatory Care Pro-
gram. Although this is difficult to assess with cool 
scientific certainty, because no clinical care pro-
gram ever is totally controlled, a number of state-
ments can be made based upon contemporary 
knowledge about the effectiveness of organized 
care for CAO. 
Symptomatic Impro vement. Most patients 
seek medical care because of adverse symptoms. 
There is no question that the development of com-
prehensive care programs has greatly improved 
the patients subjective feeling of well being. For 
example, Table 1 shows the patients' clinical as-
sessment at one and two years following entry 
into the comprehensive rehabilitation program 
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TABLE 1. 
SUBJECTIVE ANALYSIS OF SYMPTOMS 
One Year % Two Years % 
Worse 17 13 18 21 
Same 36 28 27 32 
Better 76 59 39 47 
which has been described in this report. The vast 
majority of patients remain clinically better or at 
least the same up to two years and in many cases 
longer. 
The application of care principles described 
above can be assessed by a reduction in hospital 
needs. A small group of patients requiring hospi-
talization for respiratory causes was selected, and 
the need for hospitalization following entry into a 
comprehensive care program was compared to 
the patients' prior hospital needs. In brief, Table 2 
shows that the total number of patients requiring 
hospitalizations was reduced, the total number of 
hospital days was reduced, and the average stay 
per patient reduced over a one year period com-
pared to the patient's previous performance. It 
must be admitted that the clinic and outpatient 
nature of the program emphasized independent 
existence in order to minimize hospital needs. 
This makes absolutely no difference, however, and 
the facts speak for themselves, that is, 326 hos-
pital days saved in this small group of patients. 
One has only to multiply the number of hospital 
days saved by the average cost of hospitalization 
today to gain a quick assessment of a tangible 
economic saving provided by ambulatory care 
methods. 
Return to work in an aging population is not 
common (16). Nonetheless, certain individuals 
TABLE 2. 
REDUCTION IN HOSPITAL 0AYS DURING FIRST YEAR 
OF PROGRAM COMPARED WITH PREVIOUS YEAR* 
Year Before First Year of 
Entry Program 
Total hospital days 868 542 
Number of patients hos-
pitalized (from group) 34 25 
Average hospitalized 
patients 25.5 ± 39.8 21.7 ± 30.2 
* Previously reported (20). 
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can return to gainful employment and, in some, 
this may represent a striking ·improvement over 
past performance. Most individuals who can re-
turn to work or at least maintain their level of 
gainful employment are rewarded by a continued 
sense of pride over their productive state. 
Physiologic Changes. One hundred and eighty-
two patients were evaluated for CAO and entered 
into the comprehensive care program which is re-
ported here. They were selected on the basis of hav-
ing irreversible airway obstruction with expected 
pulmonary function deterioration with age ( 4, 5, 
6, 7, 9, 11, 12, 14, 15, 16, 20, 21, 22). The over-
all physiologic changes in our series suggest that 
the expected pulmonary function deterioration is 
retarded. For example, patients at risk for one 
and two years are the subjects of Tables 3 and 44. It 
4 Symbols explained in Tables 3 and 4. 
TABLE 3. 
CoMPARISONS: PRELIMINARY VERSUS ONE YEAR 
Preliminary One Year 
Mean SD No. Mean SD p 
vc 2.66 .80 120 2.63 .81 
FEV1 1.00 .39 120 .95 .49 
MMF .44 .23 120 .41 .31 
MVV 38.5 51.1 118 37.3 19.4 
All Patients 
pH 7.40 .04 109 7.40 .04 
Pco , 40.2 8.3 108 43 . 6 11. 7 .0002 
Po, 57 . 2 8.2 95 60.1 11. 5 .025 
0, sat. 87.5 6.3 109 88.8 5.8 .05 
Dist. walked* 609.8 570.0 91 1280. 3 862.6 <.0001 
Stairs 42.3 23.5 77 68.3 32.4 <.0001 
Work on stairs 581.6 304.0 59 874.8 438.6 < .0001 
Non 0 , Patients 
pH 7.40 .04 73 7.40 .04 
Pco, 38.8 7.4 73 39.4 6.0 
Po, 59.0 7.4 67 61.2 9.1 .05 
0 , sat. 88.8 4.7 73 90.0 4.1 .02 
Work 626 .0 323.5 44 956. 1 457.1 < .0001 
Dist. walked* 671.5 616.6 67 1449.1 906.9 < .0001 
Stairs 49.7 20.9 52 76.2 28.6 < .0001 
0, Patients 
pH 7.40 .04 36 7.38 .04 .01 
Pco, 43.0 9.2 35 52.5 15.2 < .0001 
Po, 53.1 8.7 28 57.4 15.7 
0 , sat. 84.8 8.1 36 86.4 7 .9 
Work 451. 3 192.3 15 636.1 273.2 .025 
Dist. walked* 437.5 370.9 24 809.2 487.1 .01 
Stairs 36. 7 18.3 16 54. 6 28.6 .01 
vc - Vital capacity (liters) 
FEY, - Forced expiratory volume (liters/second) 
MMF - Maximal mid expiratory flow (liters /second) 
MVV - Maximal voluntary ventilation (liters / minute) 
pH -Expression of hydrogen ion concentration (Negative Lung Volume) 
Pco, - Carbon dioxide tension in arterial blood 
Po, - Oxygen tension in arterial blood 
O, sat. - Oxygen saturation in arterial blood 
Distance walked- On treadmill (various increasing rates and grades) 
Stairs - Number walked until dyspneic 
Work - Kilogram meters vertical work on stairs 
* Various increasing rates and grades. 
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TABLE 4. 
COMPARISONS: PRELIMINARY VERSUS Two YEAR 
Preliminary Two Year 
Mean SD No. Mean SD p 
vc 2.73 .80 78 2.65 .89 
FEY, 1.04 .42 78 1.00 .58 
MMF .46 .24 78 .43 .40 
MVV 41. 7 15.6 78 38.5 23.2 
All Patients 
pH 7.40 .04 73 7.40 .04 
Pco, 39.0 7.3 73 41.9 9.0 .002 
Po, 58.7 8.3 63 61.4 11.1 
0, 88.2 5.9 72 89.3 5.1 
Work 612.8 358.4 29 939.6 608.1 .0001 
Dist. walked* 789.7 557.5 41 1276.8 794.3 .001 
Stairs 45.1 24.9 34 73 .6 38.3 .0001 
Non 0, Patients 
pH 7.40 .04 52 7.41 .04 
Pc o, 37.4 5.6 52 38.9 5. 3 
Po, 60.0 7.8 49 60.2 8.0 
0, sat. 89.3 4.6 52 89.6 4.0 
Work 663.0 366.8 24 1064.2 593.2 .0001 
Dist. walked* 773 . 5 578.2 31 1429.4 801.8 .0002 
Stairs 50.3 24.1 25 79 .6 36.8 .0001 
O, Patients 
pH 7.40 .05 21 7.40 .03 
Pco, 43.1 9.2 21 49.2 11. 8 .01 
Po, 54.5 9.1 14 65.4 18.2 .025 
O, sat. 85.5 7.8 20 88.4 7.3 
Work 371. 7 194.8 5 341. 7 159.0 
Dist. walked* 839.7 513.1 10 803.6 576.7 
Stairs 39.3 15.7 7 50.0 43.1 
VC - Vital capacity (liters) 
FEY, - Forced expiratory volume (liters / second) 
MMF -Maximal mid expiratory flow (liters / second) 
MVV -Maximal voluntary ventilation (liters / minute) 
pH -Expression of hydrogen ion concentration (Negative Lung Volume) 
Pco, -Carbon dioxide tension in arterial blood 
Po, - Oxygen tension in arterial blood 
O, sat. - Oxygen saturation in arterial blood 
Distance walked- On treadmill (various increasing rates and grades) 
Stairs - Number walked until dyspneic 
Work - Kilogram meters vertical work 
* Various increasing rates and grades. 
is apparent that ventilatory function abnormalities 
do not change significantly. Oxygen tension and 
saturation are significantly increased at one year. 
Carbon dioxide rises occur only in the oxygen 
patients, but not to an important degree since pH 
remains normal (compensated). 
of the fact that the patients essentially remain 
about the same from a physiologic standpoint, they 
have not deteriorated at the expected rate. More-
over, it may be quite important that increased ex-
ercise tolerance is sustained for periods up to two 
years. 
It is probably most noteworthy that in spite Mortality. Within a 3.5 year period, 56 pa-
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TABLE 5. 
MORTALITY DATA 
At Cum Surv 
Months Risk Dead Mor % Rate % 
0-6 179 8 4.5 95.5 
6-12 169 9 9.6 90.4 
12-18 158 10 15.5 84.5 
18-24 139 12 23.2 76.8 
24-30 111 12 32.6 67.4 
30-36 74 1 33 .8 66.2 
tients have died (mean survival 1.4 years) . This is 
expressed in life table form by year in Table 5. 
An analysis of death indicates that at any point 
in time, early deaths are related to the poorest pul-
monary function measurements at time of entry 
into the program. The most common cause of 
death is combined cardiac and respiratory failure. 
No claim is currently made that the mortality 
rate is decreased except in the case of acute re-
spiratory insufficiency. Nonetheless, our popula-
tion, averaging 61 years with an FEV1 of 0.94 
liters on entry, represents a most adverse popu-
lation from the standpoint of age and loss of pul-
monary function. Clearly patients with less se-
vere forms of disease will have a better prognosis 
(5, 21). 
Summary. An ambulatory care comprehen-
sive program for emphysema and chronic bron-
chitis has been described. The basic modalities 
of therapy are patient education, bronchial hy-
giene using simple home techniques, breathing re-
training, physical reconditioning, oxygen, and ancil-
lary chemotherapeutic agents. The application of 
these principles iri care provides great sympto-
matic benefit, improved exercise tolerance, and a 
reduction in hospital needs. A reduction in the 
progressive pulmonary function deterioration which 
is expected in this disease spectrum has been ob-
served up to two years. 
In view of the immense number of patients 
with CAO, suffering and disabled, the application 
of outpatient care programs on a nationwide basis 
will help to reduce the overall social and economic 
impact of this disease complex. 
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